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Pulmonary fibrosis is one of the most severe consequences of
exposure to paraquat, an herbicide that causes rapid alveolar
inflammation and epithelial cell damage. Paraquat is known to
induce toxicity in cells by stimulating oxygen utilization via
redox cycling and the generation of reactive oxygen intermedi-
ates. However, the enzymatic activity mediating this reaction in
lung cells is not completely understood. Using self-referencing
microsensors, we measured the effects of paraquat on oxygen
flux intomurine lung epithelial cells. Paraquat (10–100M)was
found to cause a 2–4-fold increase in cellular oxygen flux. The
mitochondrial poisons cyanide, rotenone, and antimycin A pre-
vented mitochondrial- but not paraquat-mediated oxygen flux
into cells. In contrast, diphenyleneiodonium (10 M), an
NADPHoxidase inhibitor, blocked the effects of paraquat with-
out altering mitochondrial respiration. NADPH oxidases,
enzymes that are highly expressed in lung epithelial cells, utilize
molecular oxygen to generate superoxide anion.We discovered
that lung epithelial cells possess a distinct cytoplasmic diphen-
yleneiodonium-sensitive NAD(P)H:paraquat oxidoreductase.
This enzyme utilizes oxygen, requires NADH or NADPH, and
readily generates the reduced paraquat radical. Purification and
sequence analysis identified this enzyme activity as thioredoxin
reductase. Purified paraquat reductase from the cells contained
thioredoxin reductase activity, andpurified rat liver thioredoxin
reductase or recombinant enzyme possessed paraquat reduc-
tase activity. Reactive oxygen intermediates and subsequent oxi-
dative stress generated from this enzyme are likely to contribute
to paraquat-induced lung toxicity.
Exposure of humans and animals to toxic doses of paraquat
(1,1-dimethyl-4,4-bipyridylium) is known to damage the lung
leading to pulmonary edema and hypertension, acute respira-
tory distress syndrome, and progressive lung fibrosis (1). In tar-
get cells paraquat undergoes redox cycling which may contrib-
ute to its toxic actions. Several mammalian NADPH oxidases
have been identified as potential inducers of paraquat redox
cycling including cytochrome P450 reductase and nitric-oxide
synthase (2, 3). These enzymes generate a reduced paraquat
radical that can act as an electron donor (4) (see Reaction 1).
Reacting rapidly with molecular oxygen, the paraquat radical
recycles back to paraquat and in the process forms highly toxic
oxidants including superoxide anion, hydrogen peroxide,
hydroxyl radicals, and in the presence of nitric oxide, peroxyni-
trite (5–7). Cellular damage generated by these oxidants,
including lipid peroxidation, may be important in paraquat-
induced lung damage (8, 9).
Redox cycling reactions are known to consume significant
quantities of oxygen (10–12). In cells, this has the potential to
reduce levels of oxygen available formetabolic processes result-
ing in oxidative stress and toxicity (13). Previous studies have
demonstrated that paraquat can stimulate oxygen uptake by
microsomes from rat and rabbit liver and rabbit lung as well as
rabbit lung slices, alveolar macrophages, and lung fibroblasts
and in Escherichia coli (14–21). In intact cells this was only
observed in the presence of the respiratory chain inhibitor cya-
nide (18). Based on these findings, it has been suggested that
paraquat functions by diverting electron flow from cyanide-
sensitive respiration (18). In the present studies we report that
paraquat treatment of murine lung epithelial cells markedly
increases the flux of oxygen into cells in a process that is inde-
pendent of cyanide-sensitive respiration. These results are con-
sistent with enhanced oxygen utilization during paraquat redox
cycling (22). We also report that redox cycling appears to be
initiated by a one-electron reduction of the herbicide by a spe-
cific NAD(P)H oxidase. This enzymatic activity was purified
and shown to generate paraquat radical and tomediate produc-
tion of ROI.2 Thioredoxin reductase, an important antioxidant
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enzyme known to reduce thioredoxin as well as a number of
other oxidants, was identified as the active enzyme (23–28).
Paraquat has been reported to accumulate in type II alveolar
epithelial cells via an active transport system (29). Selective lung
toxicity may be the result of coupling of this transport system
with the redox cycling of paraquat by thioredoxin reductase.
MATERIALS ANDMETHODS
Chemicals and Reagents—10-Acetyl-3,7-dihydroxyphenox-
azine (AMPLEX-RED) and 3H-phenoxazine (resorufin) were
obtained fromMolecular Probes (Eugene,OR). Rat cytochrome
P450 reductase (SupersomesTM, catalog no. 456514) was from
BD Biosciences. Polyclonal antibodies to rat cytochrome P450
reductase (whole rabbit serum, catalog no. OSA-300) were
from Stressgen (Victoria, BC). Paraquat, NADPH, NADH,
horseradish peroxidase, 2,5-ADP-agarose, and all other
reagents were purchased fromSigma-Aldrich. The Superose 12
HR 10/30 size exclusion columnwas obtained fromAmersham
Biosciences. Rat liver thioredoxin reductase was obtained from
Cayman Chemical (Ann Arbor, MI).
Cells and Treatments—MLE-15 murine lung epithelial cells
were kindly provided by Dr. Jacob Finkelstein (University of
Rochester) (30). Parental CHO cells were obtained from the
American Type Culture Collection (Manassas, VA). The prep-
aration of CHO cells expressing cytochrome P450 reductase or
control empty vector has been described previously (31). Cells
were maintained in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% fetal bovine serum, penicillin (100 units/
ml), and streptomycin (100 g/ml) at 37 °C in 5% CO2 in a
humidified incubator. Tissue culture reagents were from
Invitrogen. For recordings, cells were plated at varying densities
(0.05–0.5 105 cells) onto 35-mm plastic Petri dishes in phe-
nol red-freeDulbecco’smodified Eagle’smediumwith 10% fetal
calf serum. At low density cells grow individually, whereas at
higher densities cells grow as confluent monolayers. Record-
ings were performed in phosphate-buffered saline. Paraquat
and other reagents were added sequentially directly to the
medium. Recordings were suspended during the 10–15 s
required to apply the drugs. Time was recorded continuously
during the addition of reagents.
Self-referencing Electrodes—The preparation and charac-
terization of the oxygen microsensors has been described
previously (32–35). Microsensors were used in a self-refer-
encing format to obtain a directional flux of oxygen by indi-
vidual cells andmonolayers, which is detected as a difference
in current (femptoamperes). The advantage of this method
is that it minimizes noise and random drift in the measure-
ments, factors that limit the use of standard oxygen elec-
trodes (33).
Enzyme Assays—NAD(P)H:paraquat oxidoreductase activity
was assayed in cell lysates by quantifying ROI generated via
redox cycling of paraquat (36–38), by the paraquat-dependent
consumption of oxygen or NADPH in the enzyme assay (39),
and by the NADPH-dependent formation of paraquat radical
(36, 37, 40). To prepare cell lysates for the assays, cells were
gently scraped from the culture dishes, resuspended in phos-
phate-buffered saline, and sonicated on ice with three 15-s
bursts and 1 min of cooling on ice between each sonication
burst. Disrupted cells were centrifuged (3000  g, 10 min) to
remove cellular debris, and the supernatants were either
assayed immediately for enzyme activity or further used to
purify and characterize the paraquat reductase (see further
below). Unless otherwise specified, standard reaction mixes
contained 50 mM phosphate buffer, pH 7.4, 0.5 mM NADPH or
NADH, 10–100 g of cell lysate protein, and 1–1000 M para-
quat in 0.1 ml. All enzyme assays were run at 37 °C.
Hydrogen peroxide production was assayed in 100-l
reaction mixes supplemented with 25 M 10-acetyl-3,7-di-
hydroxyphenoxazine and 0.1 units/sample of horseradish
peroxidase as previously described (41). The fluorescent
product resorufin was quantified using an HTS 7000 Plus Bio
Assay Reader (PerkinElmer Life Sciences) fitted with a
540-nm excitation filter and a 595-nm emission filter.
Kinetic assays were performed in the presence of increasing
concentrations of paraquat, and fluorescence of resorufin
was measured every 2.5 min for 30 min. The rate of hydrogen
peroxide formation was calculated based on a standard curve
generated with hydrogen peroxide in a concentration range
of 0.5–30 M. Initial velocity studies of the NAD(P)H oxi-
dase activity were performed as described previously (42). In
some experiments purified rat liver thioredoxin reductase (5
units/ml) or recombinant enzyme (9.8 units/ml) was added
in place of cell lysates.
Superoxide anion production was assayed by its ability to
oxidize hydroethidine to 2-hydroxyethidium cation in the reac-
tion mix; the product was detected using HPLC with fluores-
cence detection as described by Zhao et al. (43) with minor
modifications in the chromatography protocol. HPLC was car-
ried out using a Luna C18 (2), 3 m, 250  2.0-mm column
(Phenomenex, Torrance, CA) and a C18 guard column using a
0.2 ml/min flow rate. The column was equilibrated with 10%
CH3CN in 0.1% trifluoroacetic acid. The formed products were
separated by a linear increase in CH3CN concentration from 10
to 40% starting from10 to 45min. The signals from the detector
were recorded and analyzed by CLASS-VP software (Shimadzu
Scientific Instruments, Columbia,MD).Hydroxyl radicals were
measured by the formation of 2-hydroxyterephthalate from
terephthalate using HPLC with fluorescence detection (excita-
tion 315 nm, emission 425 nm) as described by Mishin and
Thomas (44).
The generation of paraquat radicals and depletion of
NADPH in reaction mixtures were quantified in 0.5-ml
cuvettes using a Lambda 20 UV/visible spectrophotometer
REACTION 1
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(PerkinElmer Life Sciences) scanning at 1 nm/s, recording at
1-nm intervals, and repeating the scan at 2.5-min intervals for
30 min. Paraquat radicals were quantified by increases in
absorbance at 603 nm (603  1.20  104) (45). Because para-
quat radicals are sensitive to oxygen (46), experiments were run
in filled cuvettes covered tightly with Parafilm. NADPH deple-
tionwasmeasured by decreases in absorbance at 340 nm (39). A
polarographic system fitted with a Clark oxygen electrode (Yel-
low Springs Instruments, Yellow Springs, OH) was used to
characterize oxygen utilization during enzymatic redox cycling
of paraquat.
Purification Studies—Lysates containing enzyme activity
were centrifuged in an Eppendorf 5417R high speed centrifuge
at 12,000 g for 10min to sedimentmembrane andmitochon-
drial fractions. The resulting supernatant was centrifuged in a
Beckman L7–55 ultracentrifuge at 100,000 g for 1 h, and the
microsomal and post-microsomal supernatant fractions were
collected. Approximately 40% of the paraquat oxidoreductase
activity was contained in the post-microsomal supernatant
fractions, whereas the remaining activity was present in mem-
brane and microsomal fractions. The post-mitochondrial
supernatant fractions were further purified by NADPH affinity
chromatography as described byWolff et al. (47). Briefly, 2,5-
ADP-agarosewas added (0.2 volume of settled resin per volume
of post-microsomal supernatant),
and the suspension was rocked in a
cold room for 1 h and then centri-
fuged at 2000  g for 5 min. The
supernatant was discarded, and the
resin was washed five times with
phosphate-buffered saline contain-
ing 0.1% Nonidet P-40. The resin
was then washed with phosphate-
buffered saline containing 0.1%
Nonidet P-40 and 5 mM NADPH.
The NADPH eluate was concen-
trated using an Amicon Ultra cen-
trifugal filter (Millipore, Billerica,
MA) and then fractionated by size
exclusion chromatography on a
Superose 12 HR 10/30 column (GE
Healthcare) in phosphate-buffered
saline containing 0.1% Nonidet
P-40, pH 7.4, at a flow rate of 0.3
ml/min. Absorbance of effluent
fractions was monitored at 280 nm.
The column was previously cali-
brated with Bio-Rad gel filtration
standard proteins (thyroglobulin,
Mr 60,000; bovine globulin, Mr
158,000; chicken ovalbumin, Mr
44,000). Fractions containing enzyme
activity were analyzed on 10% SDS-
polyacrylamide gels. Sequence anal-
ysis of protein bands in the gels were
performed as previously described
(48) and analyzed using NCBI Blast
algorithms.
Thioredoxin Reductase Assay—Thioredoxin reductase activ-
ity of the purified paraquat reductase or the recombinant
enzyme was assayed by the reduction of 5,5-dithiobis(2-nitro-
benzoic acid) (DTNB) in the presence of NADPH as described
by Kang et al. (49). The assay mixture contained 0.2 M phos-
phate buffer, pH 7.4, 1 mM EDTA, 0.25 mM NADPH, 1 mM
DTNB, and appropriate concentrations of purified recombi-
nant thioredoxin reductase or lung cell extract. Enzyme activity
was followed by increases in absorbance at 412 nm. In some
experiments, 100 M 1-chloro-2,4-dinitrobenzene or sodium
aurothiomalate (ATM), inhibitors of mammalian thioredoxin
reductase, were added the reaction mix.
Purification of Thioredoxin Reductase—A construct con-
taining human cytosolic thioredoxin reductase (hTR1) in
which the TGA (Sec) codon was replaced with the TGC
codon (Sec498Cys) cloned into the PET 28a vector (Nova-
gen) was kindly provided by Anton Turanov (University of
Nebraska). The thioredoxin reductase was purified from
E. coli (BL21(DE3), Novagen) transformed with the con-
struct and induced to express the enzyme as previously
described (50). Purity of the enzyme was confirmed by frac-
tionation of the purified protein on a 10% SDS-polyacrylam-
ide gel followed by Coomassie staining. Enzymatic activity
was confirmed by measuring the enzymatic reduction of
FIGURE 1. Oxygen flux near surface membranes of lung epithelial cells. Panel A, micrograph showing
self-referencing oxygen microsensor placed near an MLE-15 cell. Panel B, oxygen flux measured at increasing
distances from the cell membrane. Note that oxygen gradients were detected at distances of up to 25–50m
from the cells. Panel C, effects of antimycin A on oxygen flux in lung epithelial cells. Initially recordings were
obtained by placing the oxygenmicrosensor in the culture medium 1mm above anMLE-15 cell. After obtain-
ing a stable background (Bkgd) the probe was placed within 5 m of the cell to obtain a recording of oxygen
flux. After an additional 3 min, antimycin A (1 g/ml, final concentration) was added to the culture medium.
Panel D, effects of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP; 1M) on oxygen flux into lung
epithelial cells.
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DTNB and inhibition of enzyme activity with 1-chloro-2,4-
dinitrobenzene or ATM (51, 52).
RESULTS
Characterization of Lung Epithelial Cell Oxygen Flux—In ini-
tial experiments we used the polarographic self-referencing
microsensor to characterize oxygen utilization by lung epithe-
lial cells.When the sensor was placed 1–5m from the cells, an
oxygen gradient could readily be detected (Figs. 1, A and B). By
moving the probe away from the cells, the gradient was
mapped. Oxygen flux was detectable at distances up to 50 m
from individual cells and 400–500 m from confluent mono-
layers (Fig. 1B and not shown). The fact that oxygen gradients
could be detected in areas surrounding the cells indicates that
oxygen consumption by the cells is greater than the amount of
oxygen available by its diffusion through the medium to the
cells.
Treatment of the cells withmitochondrial electron transport
chain inhibitors rotenone (complex I), antimycin A (complex
III), or potassium cyanide (complex IV) markedly reduced the
oxygen gradients surrounding the cells, indicating that the oxy-
gen consumption was mainly mediated by mitochondrial res-
piration (Figs. 1, panel C, and 2 and not shown). This conclu-
sion is supported by our findings that the mitochondrial
protonophore uncouplers, carbonyl cyanide p-trifluorome-
thoxyphenylhydrazone and carbonyl cyanide m-chlorophenyl-
hydrazone, enhancedoxygenuptake by the cells (Figs. 1D and2B).
In further experiments we
examined the effects of paraquat
on oxygen flux into lung cells. The
addition of 100 M paraquat to the
cells resulted in a marked increase
(2–4-fold) in oxygen flux that was
evident within 15–30 s and per-
sisted for at least 30 min (Fig. 2A);
smaller increases in oxygen flux
(1.5-fold) were observed with 10
M paraquat (not shown). Neither
antimycin A nor potassium cya-
nide, which block mitochondrial
respiration, altered paraquat-in-
duced oxygen flux (Figs. 2, panels
A and D, and 3). These data indi-
cate that the effects of paraquat
are independent of mitochondrial
respiration. Pretreatment of lung
cells with inhibitors of mitochon-
drial respiration also had no effect
on paraquat-induced oxygen flux
(Fig. 2C and not shown). In con-
trast, carbonyl cyanide p-triflu-
oromethoxyphenylhydrazone and
carbonyl cyanide m-chlorophe-
nylhydrazone-induced increases
in oxygen flux were completely
blocked by potassium cyanide,
demonstrating that the actions of
the mitochondrial protonophores
and paraquat are distinct (Fig. 2B and not shown).
Paraquat has also been reported to stimulate the diaphorase
activity of nitric-oxide synthase, a process inhibited by the
nitric-oxide synthase inhibitor nitroarginine methyl ester
(NAME) (2). We found that treatment of the lung epithelial
cells with NAME had no effect on mitochondrial or paraquat-
induced oxygen flux (Fig. 2D and not shown). These data sug-
gest that nitric-oxide synthase does not affect paraquat-in-
duced oxygen uptake.
It is well recognized that several NADPH oxidases, including
cytochrome P450 reductase, contribute to extra-mitochondrial
oxygen utilization (53, 54). Paraquat is known to redox cycle via
cytochrome P450 reductase; whether it is a substrate for
NADPH oxidase is unknown (6). We found that diphenylenei-
odonium (DPI), a non-selective inhibitor of FAD-dependent
enzymes, includingNADPHoxidase, readily blocked paraquat-
induced oxygen flux into the cells without affecting mitochon-
drial respiration (Fig. 4A). This effect was independent of the
order of addition of paraquat and DPI to the cultures (compare
Figs. 4, A and B). Taken together, these data indicate that para-
quat-induced alterations in oxygen uptake are dependent on an
FAD-containing oxidoreductase activity in the cells.
To eliminate the possibility that cytochrome P450 reductase
was responsible for paraquat-induced increases in oxygen flux,
we analyzed the effects of the herbicide in cells overexpressing
the enzyme. For these studies we used CHO cells stably trans-
fected with mouse CYP450 reductase that have 35-fold more
FIGURE 2. Paraquat stimulates cellular oxygen flux. Panel A, oxygen flux into lung cells was measured after
treatment with paraquat (100 M) followed by KCN (5 mM). Panel B, cells were treated with the proton iono-
phore carbonyl cyanide m-chlorophenylhydrazone (CCCP; 1 M) followed by KCN. Panel C, oxygen flux was
measured in paraquat-treated cells pretreated with KCN. Panel D, the sensitivity of paraquat-stimulated oxy-
gen flux to NAME (5 mM) and antimycin A (1 g/ml). Bkgd, background.
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enzyme activity when compared with wild type control CHO
cells (31).3 As observed with lung epithelial cells, paraquat
caused a similar increase in oxygen flux into both wild type and
cytochrome P450 reductase-overexpressing cells. Subsequent
treatment of the cells with potassium cyanide reduced oxygen
flux due to mitochondrial respiration (Fig. 5, panels A and B).
The fact that the different cell types responded similarly to
paraquat indicates that oxygen uptake by the cells induced by
paraquat was independent of cytochrome P450 reductase
activity.
Effects of Paraquat on Lung Epithelial Cell NADPH Oxidase—
NADPH oxidase catalyzes the transfer of electrons from
NADPH to oxygen resulting in the formation of superoxide
anion. Superoxide anion rapidly dismutates into hydrogen per-
oxide and, in the presence of redox active metals, is a source of
cytotoxic hydroxyl radicals (for review, see Refs. 10 and 11).
NADPH oxidase enzyme activity can readily be quantified by
the NADPH-dependent consumption of oxygen, utilization of
NADPH, and the production of ROI due to redox cycling of
paraquat (36–39). Mitochondria-free lysates prepared from
lung epithelial cells contained very low levels of NADPH oxi-
dase enzyme activity, as measured by oxygen consumption
using a Clark oxygen electrode (Fig. 5). The addition of para-
quat to the reaction mix caused a marked increase in enzyme
activity that was dependent on NADPH. Oxygen consumption
by this enzyme was inhibited by DPI (Fig. 5). These findings are
consistent with our microsensor studies in intact cells and sup-
port the concept that the actions of paraquat aremediated by an
FAD-containing NADPH oxidase.
In further studies we characterized the paraquat-stimulated
NADPH oxidase activity in lung cell lysates. A one-electron
reduction of paraquat by this enzyme would be expected to
generate the paraquat radical (see Reaction 1). This radical is
stable at low oxygen tension and can be quantified spectropho-
tometrically by its absorption maximum at 603 nm (45). Using
sealed cuvettes to facilitate depletion of oxygen by the enzyme,
reduced paraquat was found to readily accumulate with time in
the reaction mixture in an NADPH-dependent reaction (Fig.
6A). When the cuvettes were re-oxygenated, the paraquat rad-
ical was oxidized back to paraquat, thus confirming the redox
cycling reaction (data not shown). Paraquat also stimulates
NADPH consumption in lung cell lysates. In the absence of
paraquat cell lysates were found to metabolize relatively low
basal levels of NADPH (Fig. 6C). The addition of paraquat to
the reaction mix caused a marked increase in NADPH metab-
olism (Fig. 6D). Both paraquat radical formation and NADPH
metabolism were inhibited by DPI (Fig. 6, panels B and E).
We next determined if the NADPH oxidase activity in lung
cell lysates could generate ROI in response to paraquat. For
these studies the formation of hydrogen peroxide, superoxide
anion and hydroxyl radicals was analyzed. In the absence of
paraquat, only low basal levels of hydrogen peroxide were
observed; a small increase in activity was noted when either
NADPH or NADHwas added to the assay mix (Fig. 7, panels A
and B). The addition of paraquat to the reaction resulted in a
marked increase in enzymatic activity with both cofactors.
Approximately four times more activity was evident with
NADPHwhen compared with NADH (Figs. 7, panels A and B).
The effects of paraquat on hydrogen peroxide production were
concentration- and time-dependent; maximal activity was
observed with 100 M paraquat (Fig. 7C). The accumulation of
hydrogen peroxide was abolished by catalase (10 units/ml) but
not superoxide dismutase (400 units/ml), confirming that
hydrogen peroxide was formed in the assay (data not shown).
Increased activity of paraquat in the presence of NADPHwhen
compared with NADH was due to a lower half-maximal acti-
vating concentration (Kact) and increased Vmax for paraquat.
Thus, theKact for paraquatwas 41.5MwithNADPHand 680.5
M for NADH. TheVmax for enzyme activity with paraquat was
108 nmol of H2O2/min/mg of protein and 226 nmol of H2O2/
min/mg of protein with NADH and NADPH, respectively
(Table 1). In the presence of 100 M paraquat, there was a
marked increase in the Vmax value for NADH and NADPH,
with only small changes in the Km values for these cofactors
3 J. P. Gray,D. E. Heck, V.Mishin, P. J. S. Smith, J.-Y. Hong,M. Thiruchelvam,D.A.
Cory-Slechta, D. L. Laskin, and Jeffrey D. Laskin, unpublished information.
FIGURE 3. Inhibition of paraquat-stimulated oxygen flux by DPI.MLE-15
cells were treatedwith antimycin A (1g/ml), paraquat (100M), DPI (10M),
or KCN (5 mM) as indicated in the figures. Oxygen flux was measured as
described in Fig. 1. Bkgd, background.
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(Table 2). The increase inVmax forNADPHwas5-fold greater
than for NADH, thus accounting for differences in activity of
the lysates with these pyridine nucleotides.
Paraquat was also found to stim-
ulate production of superoxide
anion and hydroxyl radicals (Fig. 7,
panels D–F). The accumulation of
these ROI was dependent on
NADPH; superoxide anion detec-
tion was inhibitable by superoxide
dismutase but not by catalase (data
not shown). Hydroxyl radical pro-
duction was supported by the pres-
ence of redox-active iron. In the
absence of iron only very low levels
of hydroxyl radicals were formed
(Fig. 7E). These findings indicate
that hydroxyl radicals are derived
from hydrogen peroxide via the
Fenton reaction (55). Hydroxyl rad-
ical production was prevented by
catalase and the hydroxyl radical
scavenger dimethyl sulfoxide (Ref.
44 and data not shown). The fact
that low levels of hydroxyl radical
were detected in the absence of
added iron may be due to the pres-
ence of traces of redox active transi-
tion metals in the cell lysates.
We also found that paraquat-in-
duced NADPH oxidase activity
was suppressed by DPI; the IC50
for this inhibitor was 1 M (Fig.
7G). In contrast, enzyme activity
was unaffected by the nitric-oxide
synthase inhibitor, NAME or the NADPH-quinone reduc-
tase inhibitors, dicoumarol or chrysin (5,7-dihydroxyfla-
vone), indicating that these enzymes do not mediate para-
quat NAD(P)H oxidoreductase activity (Fig. 7G and not
shown). Although cDNA-expressed rat cytochrome P450
reductase was inhibited by a polyclonal antibody to this
enzyme, this antibody did not block lung epithelial cell para-
quat NAD(P)H oxidoreductase activity (Fig. 7H). These data
provide additional evidence that the effects of paraquat are
not dependent on cytochrome P450 reductase.
We next characterized the lung epithelial cell paraquat
NAD(P)H oxidoreductase activity. As indicated under “Mate-
rial and Methods,” 40% of the activity was identified in
post-microsomal supernatant fractions of the cells. Enzyme
activity in this fraction was purified by 2,5-ADP-agarose
affinity and Superose size exclusion chromatography. Two
peaks with approximate molecular weights of 100 and 50
were identified. When analyzed by SDS-polyacrylamide gel
electrophoresis, the first peak contained two proteins (Mr
58,000 and 39,000), whereas the second peak contained a
single Mr 58,000 protein (not shown). Based on sequence
analysis, theMr 58,000 protein was identified as thioredoxin
reductase (Mr 57,000 (56)). The identity of the lower molec-
ular weight band was not determined. To confirm the iden-
tity of the paraquat reductase in the cytosolic fraction of the
lung epithelial cells, we next assayed the 50-kDa fraction for
FIGURE 4. Paraquat-stimulated oxygen flux in wild type CHO cells and CHO cells overexpressing cyto-
chrome P450 reductase. Panel A, paraquat-stimulated oxygen flux in wild type CHO cells. Cells were treated
with paraquat (100 M) followed by KCN (5 mM). Panel B, paraquat-stimulated oxygen flux in CHO cells over-
expressing cytochromeP450 reductase.Panels C andD, KCNpretreatmentdoesnotpreventparaquat-induced
alterations in oxygen flux in wild type CHO cells or CHO cells overexpressing cytochrome P450 reductase,
respectively. Bkgd, background.
FIGURE 5.Paraquat stimulatesNADPH-dependentoxygenconsumptionby
lungepithelial cell lysates.AClark oxygen electrodewas used to quantify oxy-
gen utilization by lung cell lysates as described under “Materials and Methods.”
Afterestablishingabase line,paraquat (100M)andNADPH(0.5mM)wereadded
in the order indicated by the arrows. Note the marked increase in oxygen con-
sumptionwhenboth paraquat andNADPHwere added. The addition of DPI (10
M) inhibited oxygen consumption (lower curve). At the end of the experiment
several grains of sodiumdithionitewere added todeplete remainingoxygen for
calibration (shownby the arrow on the lower curve, not to scale).
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thioredoxin reductase activity. We found that this fraction
readily reduced DTNB, which was inhibited by DPI and the
thioredoxin reductase inhibitors 1-chloro-2,4-dinitroben-
zene and sodium aurothiomalate (51, 52) (Fig. 8A and not
shown). These data indicate that the paraquat redox active
material purified from lung epithelial cells was thioredoxin
reductase.
To confirm the reactivity of thioredoxin reductase with
paraquat, we next analyzed its activity using recombinant
thioredoxin reductase or purified rat liver enzyme. In the
presence of NADPH, these enzymes generated low levels of
hydrogen peroxide; this reaction was markedly increased by
paraquat (Fig. 8B). Both recombinant thioredoxin reductase
and the rat liver enzyme also generated paraquat radical in
the absence of molecular oxygen in an NADPH-dependent
reaction (Fig. 8C and not shown). Furthermore, using a Clark
oxygen electrode, paraquat was shown to stimulate oxygen
utilization by the recombinant thioredoxin reductase (Fig.
8D). Oxygen utilization was inhibited by DPI. Taken
together, these data demonstrate that thioredoxin reductase
is an important component of the cellular redox cycling of
paraquat.
DISCUSSION
Of fundamental importance to
the survival of mammalian cells is
the availability of molecular oxy-
gen. Although largely used in
mitochondrial respiration, cells
also consume oxygen in numerous
extra-mitochondrial enzymatic
and non-enzymatic processes (53,
54). Indeed it has been estimated
that in healthy respiring tissues
non-mitochondrial respiration
accounts for 6–14% of oxygen
consumption (54). Redox cycling
has been recognized as one impor-
tant pathway by which cells can
utilize oxygen to generate reactive
oxygen species (46). Many endog-
enous cellular components have
the capacity to participate in redox
reactions, most notably, transition
metals and a variety of single elec-
tron donating enzymes (36–38).
Redox cycling is also thought to
mediate the action of many toxi-
cants including paraquat (20).
Paraquat is unusually toxic to the
lung, presumably due to its selective
uptake by lung cells and localized
redox cycling in the alveolar epithe-
lium (57, 58). The present studies
demonstrate that micromolar con-
centrations of paraquat increase
cellular oxygen consumption by
lung epithelial cells. This activity
was not inhibited by cyanide or anti-
mycin A, indicating that the actions of paraquat were not
dependent on mitochondrial respiration. These data are con-
sistent with redox cycling of paraquat (14, 17). Increases in
oxygen utilization by paraquat in lung epithelial cells were
inhibited by DPI, indicating that redox cycling occurs via an
FAD-dependent enzyme. However, DPI did not alter cellular
respiration, supporting the idea that the effects of paraquat are
independent of mitochondria functioning.
In our studies a highly sensitive oxygen microsensor was
used to quantify the effects of paraquat on oxygen uptake by
lung epithelial cells (33–35, 59). Of interest was our finding
that a significant gradient of oxygen is generated around
actively respiring cells. Thus, the availability of oxygen in the
cell culture medium may limit metabolic activity. In para-
quat-treated cells, a steeper gradient was observed sur-
rounding the cells. This is consistent with the idea that addi-
tional oxygen is utilized during redox cycling, potentially
limiting the amount of oxygen available for respiration. This
could result in increased oxidative stress, leading to dysregu-
lation of gene expression, altered energy reserves, and toxic-
ity (60, 61). Similar actions may also occur in bacteria where
FIGURE6.Reductionof paraquat andparaquat-stimulatedNADPHmetabolismby lung epithelial cell
lysates. Reaction mixtures containing paraquat (100 M), NADPH (0.1 mM), and cell lysates were analyzed
in 0.5 ml spectrophotometer cuvettes at 37 °C. Absorbance spectra were recorded at 2.5 min intervals.
Panel A, time-dependent increase in the production of the blue/violet paraquat radical (max 603 nm).
To measure paraquat radical reaction mixtures were preincubated for 30 min in sealed cuvettes before
analysis. Panel B, inhibitory effects of DPI (10 M) on paraquat radical formation. Data are presented as
changes in absorbance at 603 nm over time. Panel C, basal metabolism of NADPH in cell lysates in the
absence of paraquat. Reactions were run in unsealed cuvettes. Panel D, paraquat (PQ)-stimulated NADPH
metabolism. Paraquat was added directly to the cuvette and then analyzed. Panel E, inhibition of para-
quat-stimulated NADPHmetabolism by DPI. DPI (10M) and paraquat were added to the cuvette and then
analyzed.
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FIGURE 7. Paraquat redox cycling stimulates ROI production in lung epithelial cell lysates. Panels A and B, effects of NADPH or NADH, respectively, on the
formation of hydrogen peroxide as assayed using 10-acetyl-3,7-dihydroxyphenoxazine (AMPLEX-RED) (82). PQ, paraquat. Panel C, increasing concentrations of
paraquat stimulate hydrogen peroxide production. Reaction mixes contained 500 M NADPH. Panel D, redox cycling of paraquat generates superoxide anion.
Superoxide anion was assayed in reaction mixes after 45 min by the formation of 2-hydroethidium cation (indicated by the arrow) in the absence and presence of
paraquat (100 M). 2-Hydroethidine was separated from hydroethidine (second peak) by HPLC using fluorescence detection. Panels E and F, redox active iron is
required for the formation of hydroxyl radicals by paraquat. Hydroxyl radicals were assayed in reactionmixes after 3 h of incubation by the formation of 2-hydroxy-
terephthalate from terephthalate usingHPLCwith fluorescence detection. Inpanel E reactions containing 100Mparaquatwere run in the absence andpresence of
100 M Fe3/EDTA. In panel F reactions containing Fe3/EDTA were run in the absence and presence of 1 mM paraquat. Panel G, effects of inhibitors on paraquat-
stimulatedNADPHoxidase activity. Paraquat-stimulatedhydrogenperoxide formationwas assayedafter 30min in reactionmixes containingNADPHand increasing
concentrations of DPI, dicoumarol, or NAME. Panel H, effects of P450 reductase antibodies on redox cycling by paraquat. Reaction mixes containing cell lysates or
recombinantP450reductasewere incubatedwithoutandwithantibodytoP450reductaseandthenassayedforparaquat-stimulatedhydrogenperoxideproduction.
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Hassan and Fridovich (18) reported that paraquat-induced
oxygen utilization in E. coli occurs directly at the expense of
normal respiration.
Previous studies have suggested that paraquat-induced
redox cycling occurs via cytochrome P450 reductase (3, 14, 62).
In contrast, our findings demonstrate that cells overexpressing
this enzyme do not display increased oxygen uptakewhen com-
pared with non-overexpressing parental cells, indicating that
cytochrome P450 reductase is not a major contributor to para-
quat-induced changes in cellular oxygen flux. Thus, increased
oxygen utilization in response to paraquatmust bemediated by
a distinct one electron reductase. In this regard the present
studies demonstrate that murine lung epithelial cells contain a
paraquat reductase activity that utilizes molecular oxygen to
initiate paraquat redox cycling with resultant generation of
ROI. This enzymatic activity, which is FAD- and NADH- or
NADPH-dependent, readily catalyzes the generation of the
characteristic blue-violet paraquat radical (see Reaction 1) and
is distinct from cytochrome P450 reductase. Thus, in contrast
to P450 enzyme, the paraquat reductase is present in cytosolic
fractions of cells and is capable of utilizingNADHas a source of
reducing equivalents. Moreover, the paraquat reductase is not
inhibitable by antibodies to cytochrome P450 reductase. The
molecular weight of purified paraquat reductase is significantly
lower than cytochrome P450 reductase.
Under aerobic conditions the paraquat reductase activity in
lung epithelial cells was directly
associated with the NADPH-
dependent utilization of dioxygen as
paraquat radical recycled back to
paraquat. Both superoxide anion
and hydrogen peroxide were gener-
ated during the process. Interest-
ingly, in the absence of redox active
iron, only low amounts of hydroxyl
radicals were formed. This was not
unexpected since in mammalian
cells hydroxyl radical is largely
derived from hydrogen peroxide by
the Fenton reaction (55). This reac-
tion requires redox active transition
metals which are in low abundance
in mammalian cells. Thus, damage
to lung epithelial cells by paraquat-
generated hydroxyl radicals may be
limited.
Identification of the NAD(P)H:
paraquat oxidoreductase activity as
thioredoxin reductase was accom-
plished after purification and
sequence analysis. This was con-
firmed by demonstrating that the
enzyme activity purified from lung
epithelial cells contains thioredoxin
reductase activity and that highly
purified rat liver thioredoxin reduc-
tase and recombinant human thio-
redoxin reductase were able to
redox cycle paraquat and to reduce
paraquat to paraquat radical under
anaerobic conditions. It should be
FIGURE 8.Thioredoxin reductase activity of purifiedmaterial from lungepithelial cells and characteriza-
tion of paraquat redox cycling using recombinant thioredoxin reductase. Panel A, thioredoxin reductase
activity in material purified from lung epithelial cells was analyzed using DTNB as the substrate. The thio-
redoxin reductase inhibitor ATM (100 M) inhibited DTNB reduction (inset). Panel B, ability of paraquat (PQ) to
redox cycle using recombinant thioredoxin reductase or rat liver thioredoxin reductase (inset). Redox cycling
was quantified using the AMPLEX-RED reaction. Reaction mixes contained 0.5 mM NADPH and increasing
concentrations of paraquat (0–1000M; 1000M inset). Panel C, recombinant thioredoxin reductase catalyzes
the formation of paraquat radical. Reaction mixes contained NADPH and paraquat (100 M) and were run in
sealed cuvettes as in the legend to Fig. 6. Panel D, paraquat stimulates oxygen utilization by recombinant
thioredoxin reductase. Oxygen utilization was measured as indicated in the legend to Fig. 5. The arrows show
the addition of 0.5 mM NADPH, 100 M paraquat, and 10 M DPI.
TABLE 1
Activation kinetics for the production of ROI by paraquat in lung cell
extracts
Treatments Kacta Vmax
M nmol H2O2/min/mg of protein
NADH 680.5 108
NADPH 41.5 226
a Initial reaction velocities for the production of hydrogen peroxide using
increasing concentrations of paraquat were analyzed in standard reaction
mixes supplemented with 500 M NADPH or NADH.
TABLE 2
Effects of paraquat on reaction kinetics of NADH and NADPH in lung
cell extracts
Treatments Kma Vmax
M nmol H2O2/min/mg of protein
NADH 9.7 23.1
NADH paraquat 12.8 57.4
NADPH 5.9 12.7
NADPH paraquat 8.9 245
a Initial reaction velocities for the production of hydrogen peroxide using increasing
concentrations of NADH or NADPHwere analyzed in standard reactionmixes in
the absence and presence of paraquat (100 M).
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noted that, besides P450 reductase, additional paraquat reduc-
tases have been identified in both mammalian cells and in bac-
teria (18, 19, 36–38). Thus, Day et al. (2) reported that rat
nitric-oxide synthase can reduce paraquat in a process inhibit-
able by nitric-oxide synthase inhibitors that prevent NADPH
oxidation. In contrast, we found that the nitric-oxide synthase
inhibitor NAME had no effect on paraquat redox cycling in our
system, suggesting that the enzyme is not nitric-oxide synthase.
The molecular weights for nitric-oxide synthase and paraquat
reductase are also clearly distinct (63). In E. coli several para-
quat reductases have been identified including NADPH:thiore-
doxin reductase, NADPH: ferredoxin reductase, and the ferre-
doxin-containing NADPH:sulfite reductase (64, 65). It is
important to note that the thioredoxin reductases from mam-
mals and E. coli are mechanistically and structurally distinct,
making it difficult to compare activity between these two pro-
teins (56).
In addition to increasing oxygen consumption, paraquat dra-
matically reduces cellular NADPH concentrations (66).
Because NADPH is required in multiple biological pathways,
including the reduction of oxidized glutathione, the function of
cytochrome P450 enzymes, and many biosynthetic reactions,
depletion of this pyridine nucleotide can inhibit many essential
cellular functions and contribute to toxicity (67). Overstimula-
tion of the glucose 6-phosphate shunt by accumulatedNADP
may also contribute to toxicity by diverting glucose from ATP
production. This hypothesis is supported by findings that over-
expression of glucose 6-phosphate dehydrogenase enhances
paraquat toxicity in NIH-3T3 cells (68).
Attempts to ameliorate paraquat-induced lung toxicity have
met with mixed success. Although anti-inflammatory cortico-
steroids are commonly administered, there is limited evidence
that these compounds provide therapeutic benefits (69). Many
compounds that reduce production of ROI, including antioxi-
dants (N-acetylcysteine and glutathione), catechols and fla-
vonoids (epigallocatechin gallate and apocynin), and metal
chelators (desferoxamine), protect against paraquat toxicity in
cell culture systems (70–75). However, these treatments have
been less successful in various in vivomodels, particularly when
administered after, rather than before, paraquat exposure (76–
78).Our data suggest that inhibition of thioredoxin reductase in
cases of paraquat poisoning may ameliorate toxicity. Further
studies are needed to identify therapeutic inhibitors of this
enzyme in lung tissues.
In summary, the present studies show that paraquat
increases cyanide-insensitive respiration in murine lung epi-
thelial cells. Paraquat is known to function via redox cycling,
and our findings that paraquat-stimulated respiration in lung
cells was inhibited by DPI suggest that its actions are mediated
by an FAD-dependent cellular oxidoreductase. Based on these
findings we purified an NAD(P)H-dependent oxidoreductase
from the cytoplasm of lung epithelial cells and demonstrated
that it readily utilized oxygen and generated highly toxic reac-
tive oxygen species. This activity was independent of cyto-
chrome P450 reductase and identified as the FAD-containing
enzyme thioredoxin reductase. Thioredoxin reductase is an
essential enzyme for protection against oxidative stress (51,
79–81). Thus, it is surprising that it can also promote oxidative
stress by redox cycling of paraquat. Further studies are required
to characterize themechanism bywhich paraquat activates thi-
oredoxin reductase and tomore precisely define its role in para-
quat pneumotoxicity.
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